Patents by Inventor Rathbun Rhodes
Rathbun Rhodes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230301558Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.Type: ApplicationFiled: February 28, 2023Publication date: September 28, 2023Inventors: Mark Shults, Rathbun Rhodes, Stuart Updike, James H. Brauker
-
Patent number: 7471972Abstract: The present invention provides a sensor head for use in an implantable device that measures the concentration of an analyte in a biological fluid which includes: a non-conductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode. In addition, the present invention provides an implantable device including at least one of the sensor heads of the invention and methods of monitoring glucose levels in a host utilizing the implantable device of the invention.Type: GrantFiled: December 22, 2004Date of Patent: December 30, 2008Assignee: DexCom, Inc.Inventors: Rathbun Rhodes, Mark A. Tapsak, James H. Brauker, Mark C. Shults
-
Publication number: 20070213611Abstract: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.Type: ApplicationFiled: March 27, 2007Publication date: September 13, 2007Inventors: Peter Simpson, James Brauker, Paul Goode, Apurv Kamath, James Petisce, Kum Woo, Melissa Nicholas, Robert Boock, Monica Rixman, John Burd, Rathbun Rhodes, Mark Tapsak
-
Publication number: 20070032718Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: ApplicationFiled: October 10, 2006Publication date: February 8, 2007Inventors: Mark Shults, Stuart Updike, Rathbun Rhodes, Barbara Gilligan, Mark Tapsak
-
Publication number: 20060258761Abstract: Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.Type: ApplicationFiled: April 14, 2006Publication date: November 16, 2006Inventors: Robert Boock, Monica Rixman, Mark Tapsak, Mark Shults, Rathbun Rhodes
-
Publication number: 20060086624Abstract: The invention provides an implantable membrane for regulating the transport of analytes therethrough that includes a matrix including a first polymer; and a second polymer dispersed throughout the matrix, wherein the second polymer forms a network of microdomains which when hydrated are not observable using photomicroscopy at 400× magnification or less. In one aspect, the homogeneous membrane of the present invention has hydrophilic domains dispersed substantially throughout a hydrophobic matrix to provide an optimum balance between oxygen and glucose transport to an electrochemical glucose sensor.Type: ApplicationFiled: November 16, 2005Publication date: April 27, 2006Inventors: Mark Tapsak, Rathbun Rhodes, Mark Shults, Jason McClure
-
Publication number: 20060068208Abstract: The invention provides an implantable membrane for regulating the transport of analytes therethrough that includes a matrix including a first polymer; and a second polymer dispersed throughout the matrix, wherein the second polymer forms a network of microdomains which when hydrated are not observable using photomicroscopy at 400× magnification or less. In one aspect, the homogeneous membrane of the present invention has hydrophilic domains dispersed substantially throughout a hydrophobic matrix to provide an optimum balance between oxygen and glucose transport to an electrochemical glucose sensor.Type: ApplicationFiled: November 16, 2005Publication date: March 30, 2006Inventors: Mark Tapsak, Rathbun Rhodes, Mark Shults, Jason McClure
-
Publication number: 20050245795Abstract: Abstract of the Disclosure An implantable analyte sensor including a sensing region for measuring the analyte and a non-sensing region for immobilizing the sensor body in the host. The sensor is implanted in a precisely dimensioned pocket to stabilize the analyte sensor in vivo and enable measurement of the concentration of the analyte in the host before and after formation of a foreign body capsule around the sensor. The sensor further provides a transmitter for RF transmission through the sensor body, electronic circuitry, and a power source optimized for long-term use in the miniaturized sensor body.Type: ApplicationFiled: May 3, 2004Publication date: November 3, 2005Applicant: DexCom, Inc.Inventors: Paul Goode, Arnold Holmquist, Mark Tapsak, Mark Shults, Victoria Carr-Brendel, James Brauker, Paul Neale, Jason McClure, Mark Brister, Peter Simpson, Rathbun Rhodes
-
Publication number: 20050176136Abstract: Abstract of the Disclosure The preferred embodiments provide a membrane system, particularly for use on an electrochemical sensor, wherein the membrane system includes an affinity domain that dampens the effects of target interferant(s) on the sensor. The affinity domain can be layer, surface, region, and/or portion of the membrane system formed using sorbents that have an affinity for the target interferant. The sorbents can be adapted to adsorb the interferants, for example using adsorbents such as chromatography packing materials. The sorbents can also be adapted to absorb the interferants by imprinting a molecular structure on the material that forms the affinity domain such that target interferants bind to the imprinted surfaces at the molecular level.Type: ApplicationFiled: November 16, 2004Publication date: August 11, 2005Applicant: DexCom, Inc.Inventors: John Burd, Mark Tapsak, Rathbun Rhodes
-
Publication number: 20050177036Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: ApplicationFiled: December 22, 2004Publication date: August 11, 2005Inventors: Mark Shults, Stuart Updike, Rathbun Rhodes
-
Publication number: 20050124873Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that slows accurate date to be obtained over long periods of time.Type: ApplicationFiled: January 19, 2005Publication date: June 9, 2005Inventors: Mark Shults, Stuart Updike, Rathbun Rhodes, Barbara Gilligan, Mark Tapsak
-
Publication number: 20050103625Abstract: The present invention provides a sensor head for use in an implantable device that measures the concentration of an analyte in a biological fluid which includes: a non-conductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode. In addition, the present invention provides an implantable device including at least one of the sensor heads of the invention and methods of monitoring glucose levels in a host utilizing the implantable device of the invention.Type: ApplicationFiled: December 22, 2004Publication date: May 19, 2005Inventors: Rathbun Rhodes, Mark Tapsak, James Brauker, Mark Shults
-
Publication number: 20050033132Abstract: An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.Type: ApplicationFiled: May 14, 2004Publication date: February 10, 2005Inventors: Mark Shults, James Brauker, Victoria Carr-Brendel, Mark Tapsak, Dubravka Markovic, Stuart Updike, Rathbun Rhodes
-
Publication number: 20030032874Abstract: The present invention provides a sensor head for use in an implantable device that measures the concentration of an analyte in a biological fluid which includes: a non-conductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode. In addition, the present invention provides an implantable device including at least one of the sensor heads of the invention and methods of monitoring glucose levels in a host utilizing the implantable device of the invention.Type: ApplicationFiled: July 27, 2001Publication date: February 13, 2003Applicant: Dexcom, Inc.Inventors: Rathbun Rhodes, Mark A. Tapsak, James H. Brauker, Mark C. Shults